PlainRecalls
FDA Drug Low Class III Terminated

risperiDONE ORALLY DISINTEGRATING TABLETS, 2 mg, 30 Ct Bottles, Rx Only. Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India. Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC: 68382-156-06.

Reported: March 2, 2016 Initiated: January 14, 2016 #D-0725-2016

Product Description

risperiDONE ORALLY DISINTEGRATING TABLETS, 2 mg, 30 Ct Bottles, Rx Only. Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India. Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC: 68382-156-06.

Reason for Recall

Failed Impurities/Degradation Specifications: Out of specification for a known degradant.

Details

Units Affected
9504 Bottles
Distribution
US Nationwide including Puerto Rico
Location
Pennington, NJ

Frequently Asked Questions

What product was recalled?
risperiDONE ORALLY DISINTEGRATING TABLETS, 2 mg, 30 Ct Bottles, Rx Only. Manufactured by: Cadila Healthcare Ltd., Ahmedabad, India. Distributed by: Zydus Pharmaceuticals USA Inc. Pennington, NJ 08534. NDC: 68382-156-06.. Recalled by Zydus Pharmaceuticals USA Inc. Units affected: 9504 Bottles.
Why was this product recalled?
Failed Impurities/Degradation Specifications: Out of specification for a known degradant.
Which agency issued this recall?
This recall was issued by the FDA Drug on March 2, 2016. Severity: Low. Recall number: D-0725-2016.